Clinicopathologic implication of ezrin expression in non-small cell lung cancer

Korean Journal of Pathology

Volumn 46, Issue 5, 2012, Pages 470-477

  Lee, Ho Won ^a   Kim, Eui Han ^a   Oh, Mee Hye ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Carcinoma,Non small cell lung; Ezrin; Prognosis

Indexed keywords

EID: 84873898835     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2012.46.5.470     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Tsuchiya T, Akamine S, Muraoka M, et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 2007; 56: 341-348.
3. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002; 3: 586-599.
4. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004; 10: 201-204.
5. Brambilla D, Fais S. The Janus-faced role of Ezrin in "linking" cells to either normal or metastatic phenotype. Int J Cancer 2009; 125: 2239-2245.
6. Bruce B, Khanna G, Ren L, et al. Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 2007; 24: 69-78.
7. Zhao J, Zhang X, Xin Y. Up-regulated expression of ezrin and c-Met proteins are related to the metastasis and prognosis of gastric carcinomas. Histol Histopathol 2011; 26: 1111-1120.
8. Elzagheid A, Korkeila E, Bendardaf R, et al. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol 2008; 39: 1737-1743.
9. Korkeila EA, Syrjänen K, Bendardaf R, et al. Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer. Hum Pathol 2011; 42: 384-392.
10. Wang L, Lin GN, Jiang XL, Lu Y. Expression of ezrin correlates with poor prognosis of nasopharyngeal carcinoma. Tumour Biol 2011; 32: 707-712.
11. Xie JJ, Xu LY, Wu ZY, et al. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma. J Surg Oncol 2011; 104: 538-543.
12. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 2005; 7: R365-R373.
13. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004; 10: 182-186.
14. Kim C, Shin E, Hong S, et al. Clinical value of ezrin expression in primary osteosarcoma. Cancer Res Treat 2009; 41: 138-144.
15. Lee JS, Jin MS, Lee JE, Kim MS, Jeon DG, Koh JS. Prognostic significance of ezrin expression in liposarcoma. Korean J Pathol 2008; 42: 270-276.
16. Carneiro A, Bendahl PO, Åkerman M, et al. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas. J Clin Pathol 2011; 64: 689-694.
17. Abdou AG, Maraee AH, El-Sayed EM, Elnaidany NF. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas. Ann Diagn Pathol 2011; 15: 394-401.
18. Federici C, Brambilla D, Lozupone F, et al. Pleiotropic function of ezrin in human metastatic melanomas. Int J Cancer 2009; 124: 2804-2812.
19. Tokunou M, Niki T, Saitoh Y, Imamura H, Sakamoto M, Hirohashi S. Altered expression of the ERM proteins in lung adenocarcinoma. Lab Invest 2000; 80: 1643-1650.
20. Deng X, Tannehill-Gregg SH, Nadella MV, et al. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin Exp Metastasis 2007; 24: 107-119.
21. Wang J, Zhang M, Chen L, Huang W, Ma H. Expression and correlation of ezrin and survivin in non-small cell lung cancer. Chinese-German J Clin Oncol 2010; 9: 381-384.
22. Travis WD, Brambilla E, Müller-Hermelink K, Harris CC. World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press, 2004; 10.
23. Travis WD; IASLC Staging Committee. Reporting lung cancer pathology specimens. Impact of the anticipated 7th edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology 2009; 54: 3-11.
24. Patara M, Santos EM, Coudry Rde A, Soares FA, Ferreira FO, Rossi BM. Ezrin expression as a prognostic marker in colorectal adenocarcinoma. Pathol Oncol Res 2011; 17: 827-833.
25. Jung EA, Cho HD, Lee JH, Oh MH. Clinicopathological significance of S100A4 expression in non-small cell lung carcinomas. Korean J Pathol 2010; 44: 477-482.
26. Bretscher A. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 1989; 108: 921-930.
27. Hiscox S, Jiang WG. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 1999; 112 Pt 18: 3081-3090.
28. McClatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 2003; 3: 877-883.
29. Fiévet B, Louvard D, Arpin M. ERM proteins in epithelial cell organization and functions. Biochim Biophys Acta 2007; 1773: 653-660.
30. Wan X, Mendoza A, Khanna C, Helman LJ. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res 2005; 65: 2406-2411.